Sökning: "Abnormal Returns"

Visar resultat 11 - 15 av 769 uppsatser innehållade orden Abnormal Returns.

1. 11. The Impact of ESG-Scores on Portfolio Performance - A quantitative study on sustainable investments.

   Master-uppsats, Göteborgs universitet/Graduate School

   Författare :Max Ehrnström; Yacob Nehmé; [2023-06-29]
   Nyckelord :ESG investing; Abnormal returns; Sustainable investing and Financial performance;

   Sammanfattning : This report examines the relationship between ESG-scores and portfolio returns using the Fama-French five-factor and Carhart four-factor models. The data is collected from Refinitiv (2023) between 2003 and 2021 and consists of firms listed on the NYSE and NASDAQ stock exchange. LÄS MER

3. 12. Seasoned Equity Offerings and Disclosure Sentiment Effects: Evidence from the U.S.

   Master-uppsats, Göteborgs universitet/Graduate School

   Författare :Max Mauritz; Phornchanok Phojan; [2023-06-29]
   Nyckelord :Seasoned Equity Offerings; Long-Term Event Study; Buy-and-Hold Abnormal Returns; Textual Analysis; Disclosure Sentiment; Disclosure Tone;

   Sammanfattning : This paper updates the data regarding Seasoned Equity Offering firms (SEOs) long-term performance and finds evidence in line with prior research that they underperform in the longterm. Furthermore, using automated textual analysis on the relevant disclosure filings SEO firms in the United States publish (Form 10-K, Form 8-K and Form 424B), we investigate the relationship between disclosure sentiment variables and long-term return performance. LÄS MER

4. 13. The Insider Scoop: A Study on the Effect of Insider Trading and Abnormal Stock Returns During Uncertain Market Condition of the Russia-Ukraine War

   C-uppsats, Handelshögskolan i Stockholm/Institutionen för finansiell ekonomi

   Författare :Louise Williams; Sigge Arvidsson; [2023]
   Nyckelord :Russian-Ukrainian War; Insider Trading; Abnormal Stock Return; Nasdaq Stockholm; Uncertainty;

   Sammanfattning : This paper examines how insider transactions of stocks listed on Nasdaq Stockholm generate abnormal returns during the period 2016-2022 and extends on how abnormal returns react in times of uncertainty, i.e., after the Invasion of Ukraine. LÄS MER

5. 14. Does Key Audit Matters, matter? : En kvantitativ studie om marknadens reaktion på KAM

   Uppsats för yrkesexamina på avancerad nivå, Umeå universitet/Företagsekonomi

   Författare :Tobias Norlund; Johan Marklund; [2023]
   Nyckelord :Key Audit Matters; Cumulative Abnormal Returns; utökad revisionsberättelse; ISA 701;

   Sammanfattning : En efterfrågan efter mer informativa revisionsberättelser har över tid växt fram, vilketledde till att The International Auditing and Assurance Standards Board (IAASB) år 2015introducerade ISA 701: “Communicating Key Audit Matters in the Independent Auditor’sReport”. ISA 701 är en ny standard som innebär att revisorer ska inkludera områden somde finner vara av särskild betydelse i företaget under revision i sin revisionsberättelse,vilket började gälla på finansiella rapporter för noterade bolag avseende perioder somslutade på, eller efter, 15:e december år 2016. LÄS MER

7. 15. Predictability of Shareholder Return in Medical Device Companies : Investment Decisions from thePerspective of an Investment Firm

   Master-uppsats, KTH/Skolan för industriell teknik och management (ITM)

   Författare :Daniel Gröttheim; [2023]
   Nyckelord :Medical device companies; pre-market approval; total return; abnormal return; stock return prediction; market anomalies; free cash flow yield; efficient markets; financial crisis; investment firm; Medicintekniska företag; förmarknadsgodkännande; totalavkastning; abnorm avkastning; aktieavkastningsförutsägbarhet; marknadsavvikelser; avkastning på fritt kassaflöde; effektiva marknader; finanskris; investeringsföretag;

   Sammanfattning : The medical device industry has seen rapid growth in recent years, and the increasing valuations has caught the attention of investors. Although their growth has outpaced many indices, medical device companies’ reliance on capital to finance research, patents, and clinical testing to reach pre-market approval makes due-diligence and the investment research process especially complex. LÄS MER